Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Following Most Recent GMP Inspection By MHRA, Autolus Therapeutics' Nucleus Manufacturing Facility In Stevenage Has Obtained Manufacturer's Importation Authorization Enabling To Manufacture For Global Commercial, Clinical Product Supply Effective March 18

Author: Benzinga Newsdesk | March 12, 2024 07:13am

Posted In: AUTL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist